Compile Data Set for Download or QSAR
maximum 50k data
Found 329 with Last Name = 'pei' and Initial = 'y'
TargetMu-type opioid receptor(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50599918(CHEMBL3736287)
Affinity DataKi:  1nMAssay Description:Binding affinity at MOR (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSubstance-P receptor(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50599918(CHEMBL3736287)
Affinity DataKi:  2.20nMAssay Description:Binding affinity at human NK1R assessed as inhibition constantMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50599918(CHEMBL3736287)
Affinity DataKi:  5nMAssay Description:Binding affinity at DOR (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Nanjing University Of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50601783(CHEMBL5184678)
Affinity DataKi:  590nMAssay Description:Binding affinity to NMDAR (unknown origin) assessed as inhibition constant by [3H]MK-801 binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHistone deacetylase 6(Homo sapiens (Human))
Nanjing University Of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50601782(CHEMBL5198547)
Affinity DataIC50:  0.00950nMAssay Description:Inhibition of HDAC6 (unknown origin) by microtiter plate reader analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Chinese Academy Of Sciences

Curated by ChEMBL
LigandPNGBDBM50571444(CHEMBL4858291)
Affinity DataIC50:  0.0170nMAssay Description:Inhibition of human SHP2 catalytic activity in human MV4-11 cellsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Chinese Academy Of Sciences

Curated by ChEMBL
LigandPNGBDBM38019(US10093646, Compound 1 | US10301278, Example 00003...)
Affinity DataIC50:  0.145nMAssay Description:Inhibition of human SHP2 catalytic activity in human MV4-11 cellsMore data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636214(US20230365541, Compound 60, isomer 1)
Affinity DataIC50:  0.180nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Chinese Academy Of Sciences

Curated by ChEMBL
LigandPNGBDBM50571445(CHEMBL4871539)
Affinity DataIC50:  0.202nMAssay Description:Inhibition of human SHP2 catalytic activity in human MV4-11 cellsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636198(US20230365541, Compound 42, isomer 2)
Affinity DataIC50:  0.230nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636217(US20230365541, Compound 61, isomer 2)
Affinity DataIC50:  0.25nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636203(US20230365541, Compound 45, isomer 1)
Affinity DataIC50:  0.280nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636208(US20230365541, Compound 49, isomer 2)
Affinity DataIC50:  0.320nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636209(US20230365541, Compound 53, isomer 1)
Affinity DataIC50:  0.330nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636197(US20230365541, Compound 42, isomer 1)
Affinity DataIC50:  0.340nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636215(US20230365541, Compound 60, isomer 2)
Affinity DataIC50:  0.340nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636205(US20230365541, Compound 47, isomer 1)
Affinity DataIC50:  0.340nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636204(US20230365541, Compound 45, isomer 2)
Affinity DataIC50:  0.350nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636191(US20230365541, Compound 39, isomer 1)
Affinity DataIC50:  0.420nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636200(US20230365541, Compound 43, isomer 2)
Affinity DataIC50:  0.420nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636172(4-(7-chloro-2,4-dimethyl-5-(((6-methyl-4-(methylth...)
Affinity DataIC50:  0.430nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636213(US20230365541, Compound 59, isomer 2)
Affinity DataIC50:  0.440nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636180(US20230365541, Compound 29 | methyl-4-(7-chloro-2,...)
Affinity DataIC50:  0.440nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636196(US20230365541, Compound 41, isomer 2)
Affinity DataIC50:  0.440nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636189(7-chloro-2-(1-(cyclobutylmethyl)piperidin-4-yl)-2,...)
Affinity DataIC50:  0.440nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636210(US20230365541, Compound 57, isomer 1)
Affinity DataIC50:  0.460nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636158(US20230365541, Compound 4, isomer 1)
Affinity DataIC50:  0.460nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636201(US20230365541, Compound 44, isomer 1)
Affinity DataIC50:  0.480nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636173(7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-...)
Affinity DataIC50:  0.480nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636167(US20230365541, Compound 9, isomer 2)
Affinity DataIC50:  0.480nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636211(US20230365541, Compound 57, isomer 2)
Affinity DataIC50:  0.490nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636179(7-chloro-2-(1-((3,3-difluorocyclobutyl)methyl)pipe...)
Affinity DataIC50:  0.490nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone acetyltransferase p300(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50580965(CHEMBL5090239)
Affinity DataIC50:  0.490nMAssay Description:Inhibition of p300 (unknown origin) preincubated for 15 mins followed by addition of substrate [3H] Ac-CoA and measured after 60 mins by liquid scint...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636199(US20230365541, Compound 43, isomer 1)
Affinity DataIC50:  0.490nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636207(US20230365541, Compound 49, isomer 1)
Affinity DataIC50:  0.510nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636194(US20230365541, Compound 40, isomer 2)
Affinity DataIC50:  0.510nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636157(US20230365541, Compound 3, isomer 2)
Affinity DataIC50:  0.510nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone acetyltransferase p300(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50580965(CHEMBL5090239)
Affinity DataIC50:  0.510nMAssay Description:Inhibition of p300 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636164(US20230365541, Compound 8, isomer 1)
Affinity DataIC50:  0.510nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636202(US20230365541, Compound 44, isomer 2)
Affinity DataIC50:  0.510nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636177(7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-...)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636161(US20230365541, Compound 6, isomer 1)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636182(7-chloro-2-(1-((2,2-difluorocyclopropyl)methyl)pip...)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636195(US20230365541, Compound 41, isomer 1)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636216(US20230365541, Compound 61, isomer 1)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636178(7-chloro-2-(1-(cyclopropylmethyl)piperidin-4-yl)-2...)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636163(US20230365541, Compound 11, isomer 1 | US202303655...)
Affinity DataIC50:  0.520nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636188(8-(7-chloro-2,4-dimethyl-5-(((6-methyl-4-(methylth...)
Affinity DataIC50:  0.550nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone acetyltransferase p300(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50580962(CHEMBL5082755)
Affinity DataIC50:  0.560nMAssay Description:Inhibition of p300 (unknown origin) preincubated for 15 mins followed by addition of substrate [3H] Ac-CoA and measured after 60 mins by liquid scint...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase EZH2(Homo sapiens (Human))
Haisco Pharmaceuticals

US Patent
LigandPNGBDBM636160(US20230365541, Compound 10, isomer 1 | US202303655...)
Affinity DataIC50:  0.560nMAssay Description:The compounds were dissolved in DMSO, formulated into 10 mM solutions and serially diluted with DMSO to obtain 100-fold the final concentration. 200 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 329 total ) | Next | Last >>
Jump to: